Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 300
6
Diseases
11
Unique genes
0.194
Avg. similarity score
Dermatitis herpetiformis
Most-connected disease (4 links)
Disease
Searched: Extrinsic allergic alveolitis
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Extrinsic allergic alveolitis
Dermatitis herpetiformis
Refractory anemia
Spinal cord compression
Pregnancy disorder
cutis laxa, autosomal dominant 1
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Dermatitis herpetiformis | 4 | 4 | 3 |
| Refractory anemia | 4 | 4 | 1 |
| Spinal cord compression | 4 | 4 | 3 |
| Pregnancy disorder | 3 | 3 | 4 |
| Extrinsic allergic alveolitis | 2 | 2 | 4 |
| cutis laxa, autosomal dominant 1 | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| TNF | 5 / 6 | Dermatitis herpetiformis, Extrinsic allergic alveolitis, Pregnancy disorder, Refractory anemia and 1 more |
| ELN | 2 / 6 | cutis laxa, autosomal dominant 1, Dermatitis herpetiformis |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Herpes simplex virus 1 infection | KEGG | 4 / 182 | 24.0× | 1.55e-5 | 5.10e-4 ✓ sig. |
| IL-17 signaling pathway | KEGG | 3 / 94 | 34.8× | 7.32e-5 | 1.81e-3 ✓ sig. |
| Viral protein interaction with cytokine and cytokine receptor | KEGG | 3 / 100 | 32.8× | 8.81e-5 | 2.10e-3 ✓ sig. |
| TNF signaling pathway | KEGG | 3 / 119 | 27.5× | 1.48e-4 | 3.15e-3 ✓ sig. |
| Fluid shear stress and atherosclerosis | KEGG | 3 / 141 | 23.2× | 2.44e-4 | 4.68e-3 ✓ sig. |
| Type I diabetes mellitus | KEGG | 2 / 44 | 49.6× | 7.07e-4 | 1.08e-2 ✓ sig. |
| Interleukin-10 signaling | Reactome | 2 / 47 | 46.5× | 8.06e-4 | 1.19e-2 ✓ sig. |
| Lipid and atherosclerosis | KEGG | 3 / 216 | 15.2× | 8.51e-4 | 1.24e-2 ✓ sig. |
| Malaria | KEGG | 2 / 50 | 43.7× | 9.12e-4 | 1.30e-2 ✓ sig. |
| Human cytomegalovirus infection | KEGG | 3 / 226 | 14.5× | 9.70e-4 | 1.37e-2 ✓ sig. |
| TNFR2 non-canonical NF-kB pathway | Reactome | 2 / 69 | 31.6× | 1.73e-3 | 2.13e-2 ✓ sig. |
| Cytokine-cytokine receptor interaction | KEGG | 3 / 298 | 11.0× | 2.15e-3 | 2.50e-2 ✓ sig. |
| Antigen processing and presentation | KEGG | 2 / 81 | 27.0× | 2.38e-3 | 2.68e-2 ✓ sig. |
| Rheumatoid arthritis | KEGG | 2 / 95 | 23.0× | 3.25e-3 | 3.34e-2 ✓ sig. |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | Reactome | 1 / 4 | 273× | 3.66e-3 | 3.64e-2 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| positive regulation of chronic inflammatory response to antigenic stimulus | GO:0002876 | 2 / 2 | 1,699× | 3.15e-7 | 3.27e-5 ✓ sig. |
| animal organ morphogenesis | GO:0009887 | 4 / 130 | 52.3× | 7.11e-7 | 6.41e-5 ✓ sig. |
| response to isolation stress | GO:0035900 | 2 / 4 | 849× | 1.89e-6 | 1.42e-4 ✓ sig. |
| response to hypoxia | GO:0001666 | 4 / 176 | 38.6× | 2.38e-6 | 1.71e-4 ✓ sig. |
| positive regulation of humoral immune response mediated by circulating immunoglobulin | GO:0002925 | 2 / 5 | 680× | 3.15e-6 | 2.14e-4 ✓ sig. |
| humoral immune response | GO:0006959 | 3 / 58 | 87.9× | 4.60e-6 | 2.89e-4 ✓ sig. |
| positive regulation of glial cell proliferation | GO:0060252 | 2 / 22 | 154× | 7.23e-5 | 2.46e-3 ✓ sig. |
| response to lipopolysaccharide | GO:0032496 | 3 / 161 | 31.7× | 9.84e-5 | 3.10e-3 ✓ sig. |
| positive regulation of mitotic nuclear division | GO:0045840 | 2 / 29 | 117× | 1.27e-4 | 3.72e-3 ✓ sig. |
| negative regulation of fibroblast proliferation | GO:0048147 | 2 / 35 | 97.1× | 1.85e-4 | 4.95e-3 ✓ sig. |
| positive regulation of extrinsic apoptotic signaling pathway | GO:2001238 | 2 / 38 | 89.4× | 2.19e-4 | 5.54e-3 ✓ sig. |
| positive regulation of nitric oxide biosynthetic process | GO:0045429 | 2 / 42 | 80.9× | 2.68e-4 | 6.41e-3 ✓ sig. |
| response to xenobiotic stimulus | GO:0009410 | 3 / 248 | 20.6× | 3.52e-4 | 7.75e-3 ✓ sig. |
| vasodilation | GO:0042311 | 2 / 50 | 68.0× | 3.80e-4 | 8.17e-3 ✓ sig. |
| response to activity | GO:0014823 | 2 / 52 | 65.3× | 4.11e-4 | 8.66e-3 ✓ sig. |
Pairs within this cluster, by significance
| Disease A ⇵ | Disease B ⇵ | Similarity score ⇵ | Shared genes ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| cutis laxa, autosomal dominant 1 | Dermatitis herpetiformis | 0.250 | 1 | 1.95e-4 | 5.35e-4 ✓ sig. |
| Dermatitis herpetiformis | Refractory anemia | 0.250 | 1 | 1.95e-4 | 5.35e-4 ✓ sig. |
| Refractory anemia | Spinal cord compression | 0.250 | 1 | 1.95e-4 | 5.35e-4 ✓ sig. |
| Extrinsic allergic alveolitis | Refractory anemia | 0.200 | 1 | 2.60e-4 | 6.51e-4 ✓ sig. |
| Pregnancy disorder | Refractory anemia | 0.200 | 1 | 2.60e-4 | 6.51e-4 ✓ sig. |
| Dermatitis herpetiformis | Spinal cord compression | 0.167 | 1 | 5.84e-4 | 1.16e-3 ✓ sig. |
| Dermatitis herpetiformis | Pregnancy disorder | 0.143 | 1 | 7.79e-4 | 1.41e-3 ✓ sig. |
| Extrinsic allergic alveolitis | Spinal cord compression | 0.143 | 1 | 7.79e-4 | 1.41e-3 ✓ sig. |
| Pregnancy disorder | Spinal cord compression | 0.143 | 1 | 7.79e-4 | 1.41e-3 ✓ sig. |